new HIV drugs

New HIV Drugs and Formulations in the Near Future (CROI 2013 Presentation)

All of the presentations in this section were great. The one on new drugs is contained in the last set of slides (blue slides at 1:22:46) http://webcasts.retroconference.org/console/player/19437?mediaType=podiumVideo For individual reports on each drug (Thanks to Natap.org): NEW HIV DRUGS at CROI Dolutegravir Treatment Response and Safety by Key Subgroups in Treatment Naive HIV Infected Individuals – (03/16/13) Dolutegravir (DTG) …

New HIV Drugs and Formulations in the Near Future (CROI 2013 Presentation) Read More »

FDA approved Jak inhibitors and their potential use in HIV – Interview with Dr Raymond Schinazi

As part of my work as a cure and salvage treatment activist, I am constantly searching for treatment options that could serve two purposes: existing medications that could help patients with multidrug resistance and at the same time be used as an approach to cure HIV.  Since my non profit (Program for Wellness Restoration) has …

FDA approved Jak inhibitors and their potential use in HIV – Interview with Dr Raymond Schinazi Read More »

New HIV Drugs in the Pipeline – 2012

Gilead has completed and released 48-week data from ongoing phase 3 studies of a four-drug fixed dose combination (elvitegravir, cobicistat, tenofovir, and FTC- called QUAD), as it has with studies of the integrase inhibitor elvitegravir and the pharmacokinetic booster cobicistat.  QUAD  will likely be approved for treatment naive patients after August this year.  Results from …

New HIV Drugs in the Pipeline – 2012 Read More »

The Coming Crisis in HIV Drug Development

Excellent article by Paul Dalton Project Inform The Coming Crisis in HIV Drug DevelopmentBy Paul Dalton June 16, 2008 The last few years have seen tremendous progress in treating people with advanced and drug-resistant HIV. Four powerful drugs became available that either overcame drug resistance (Prezista [darunavir, TMC-114], Intelence [etravirine, TMC-125]) or were from entirely …

The Coming Crisis in HIV Drug Development Read More »

Scroll to Top